A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Clinical trial NCT06549595 · RECRUITING

Trial details

NCT number: NCT06549595
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Untreated Follicular Lymphoma

Start date: 2024-08-07
Primary completion: 2031-11-26
Enrollment: 1018

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.